Jason Mills, an analyst from Canaccord Genuity, believes that the medical technology sphere may see some M&A consolidation over the next year despite the market's recent slowdown in takeover activity. Many companies are sitting on cash, and he believes profitable opportunities abound in biomedical devices.
In a note to investors on this earnings season, Mills identified five companies in the sub-industry that he believes are the most likely candidates. These companies all specialize in products used to treat or detect cardiovascular disorders.
The five companies are listed below, along with Mills reasoning. Do you think these biomedical companies are likely candidates for a takeover? (Click here to access free, interactive tools to analyze these ideas.)
2. Heartware International
3. The Spectranetics Corporation
Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the stocks mentioned above. Analyst ratings sourced from Zacks Investment Research.
Kapitall's Alexander Crawford.does not own any of the shares mentioned above.
Motley Fool newsletter services have recommended buying shares of Volcano. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.